Cellid, Co., Ltd. (299660.KQ)

KRW 5500.0

(-7.25%)

Operating Income Summary of Cellid, Co., Ltd.

Cellid, Co., Ltd.'s latest annual operating income in 2023 was -12.19 Billion KRW , down -0.39% from previous year.
Cellid, Co., Ltd.'s latest quarterly operating income in 2024 Q2 was -3.46 Billion KRW , down -33.97% from previous quarter.
Cellid, Co., Ltd. reported an annual operating income of -14.91 Billion KRW in 2022, up 31.25% from previous year.
Cellid, Co., Ltd. reported an annual operating income of -21.68 Billion KRW in 2021, down -310.27% from previous year.
Cellid, Co., Ltd. reported a quarterly operating income of -3.46 Billion KRW for 2024 Q2, down -33.97% from previous quarter.
Cellid, Co., Ltd. reported a quarterly operating income of -3.24 Billion KRW for 2023 Q1, down -44.95% from previous quarter.

Annual Operating Income Chart of Cellid, Co., Ltd. (2023 - 2015)

Historical Annual Operating Income of Cellid, Co., Ltd. (2023 - 2015)

Year	Operating Income	Operating Income Growth
2023	-12.19 Billion KRW	-0.39%
2022	-14.91 Billion KRW	31.25%
2021	-21.68 Billion KRW	-310.27%
2020	-5.28 Billion KRW	-12.97%
2019	-4.67 Billion KRW	-15.52%
2018	-4.05 Billion KRW	-72.26%
2017	-2.35 Billion KRW	-31.47%
2016	-1.78 Billion KRW	-51.73%
2015	-1.17 Billion KRW	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	-2.41 Billion KRW	19.47%
2024 Q2	-3.46 Billion KRW	-33.97%
2023 Q1	-3.24 Billion KRW	-44.95%
2023 FY	-14.96 Billion KRW	-0.39%
2023 Q4	-3 Billion KRW	23.28%
2023 Q3	-3.91 Billion KRW	10.59%
2023 Q2	-4.38 Billion KRW	-34.95%
2022 Q4	-2.23 Billion KRW	62.51%
2022 FY	-14.91 Billion KRW	31.25%
2022 Q1	-5.54 Billion KRW	16.33%
2022 Q3	-5.97 Billion KRW	13.86%
2022 Q2	-6.93 Billion KRW	-24.98%
2021 Q3	-5.16 Billion KRW	-1.42%
2021 Q4	-6.63 Billion KRW	-28.48%
2021 Q1	-2.83 Billion KRW	-36.95%
2021 Q2	-5.08 Billion KRW	-79.2%
2021 FY	-21.68 Billion KRW	-310.27%
2020 Q4	-2.07 Billion KRW	-56.84%
2020 Q1	-1.45 Billion KRW	-52.15%
2020 Q2	-432.78 Million KRW	70.32%
2020 Q3	-1.32 Billion KRW	-205.49%
2020 FY	-5.28 Billion KRW	-12.97%
2019 Q1	-599.98 Million KRW	39.05%
2019 FY	-4.67 Billion KRW	-15.52%
2019 Q4	-958.33 Million KRW	-2.09%
2019 Q3	-938.71 Million KRW	9.19%
2019 Q2	-1.03 Billion KRW	-72.29%
2018 Q2	-346.7 Million KRW	27.72%
2018 FY	-4.05 Billion KRW	-72.26%
2018 Q1	-479.69 Million KRW	-46.19%
2018 Q4	-984.43 Million KRW	0.0%
2017 FY	-2.35 Billion KRW	-31.47%
2017 Q1	-287.1 Million KRW	0.0%
2017 Q4	-328.13 Million KRW	0.0%
2016 FY	-1.78 Billion KRW	-51.73%
2015 FY	-1.17 Billion KRW	0.0%

Peer Operating Income Comparison of Cellid, Co., Ltd.

Name	Operating Income	Operating Income Difference
Sam Chun Dang Pharm. Co., Ltd	9.55 Billion KRW	227.596%
Hyundai Bioscience Co., Ltd.	-9.78 Billion KRW	-24.658%
ST Pharm Co.,Ltd.	31.03 Billion KRW	139.303%
ABL Bio Inc.	-27.32 Million KRW	-44545.306%